MARK3 and Alzheimer disease: As MARK3 is a tau kinase associated with tau S262 phosphorylation in the early stages of AD pathogenesis (24), and because mutations in closely related MARK4 can significantly increase AD risk, promote hyperphosphorylation of tau, and induce neuron toxicity (33), we sought to investigate the functional consequences of MARK3 APA in neurons.